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i:10.1016/j.rmed.2008.03.006Professional bodies, training organisations, research char-
ities and organisations representing patient groups with an
interest in lung health recently joined forces to form a new
organisation e the UK Respiratory Research Collaborative
(UKRRC) e in an attempt to raise the profile of respiratory
research in the UK.1 Central to these efforts is the need to
develop a mechanism through which this committed, but
diverse group of organisations can identify and jointly agree
research projects of national importance to the UK respira-
tory research community, which could then be prioritised
these with a view to presenting them to prospective na-
tional funding bodies.2,3 This editorial reflects on our expe-
riences of developing a scientifically robust means of
undertaking this prioritisation work. In addition, we use
this as an opportunity to share key findings from our first re-
search prioritisation exercise conducted in 2007.Rationale for formal consensus building
approaches
Each of the 17 organisations represented on the UKRRC
nominates a member of their body to serve on the national
collaborative. In addition to these representative
members are five academic co-opted members, who have
been chosen through a process of nomination and election
by representative members. Given this diversity of8 Elsevier Ltd. All rights reservedrepresentation, it is to be expected that there are,
depending on individual members experiences, disciplinary
background, subject specific methodological expertise and
stakeholder group representative, a wide range of perspec-
tives on which questions are most pressing. In such in-
stances of likely divergent opinion, formal consensus
building techniques can be used to achieve agreement in
a fair, transparent and cohesive manner.4 Such techniques
have the potential advantages of facilitating participation
of those reluctant to openly contribute in group settings;
additionally, they should reduce the risk that group deci-
sion-making is dominated by individuals or vested-interest
groups and is as a result of divisive process.
There are a number of formal consensus building
techniques, but these tend to share three key components:
anonymity of individual responses thereby allowing individ-
uals to freely state their opinions in private without fear of
the need to bow to peer group pressures; controlled feed-
back of summary responses thereby allowing individuals to
reflect on the group perspective; and iteration, which al-
lows individuals to re-evaluate their positions in the light
of this controlled feedback of the overall group response.4,5
Delphi technique
Of these approaches, the Delphi technique is the best known
and most widely used formal technique in healthcare.
Table 1 Main steps in undertaking a Delphi exercise
 Expert panel: Constructing a panel of experts and
obtaining their agreement to participate
in the experiment.
 Round 1: Experts are invited, anonymously, to
contribute their ideas on the subject in question
(e.g. key research questions for the UK respiratory
research community) and these individual responses
are then summarised and circulated amongst the
panel, typically in the form of a questionnaire.
 Round 2: Panel members then individually rank their
level of agreement with each statement (or in this
case research question) and these individual responses
are then summarised and circulated to the panel with
a repeat questionnaire.
 Round 3: Panel members are then given the
opportunity to revise their opinions in the light of the
findings of the previous round and these results
are again summarised and fed back to the panel.
 Reaching agreement: The above-described three
rounds are usually sufficient to allow an acceptable
degree of agreement to emerge amongst most panel
members, but if not a final fourth round can be
conducted.
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its origins lie in research with the US air force, where it was
first used to estimate the least numbers of bombs the US
would need to drop on industrial targets in the USSR to seri-
ously incapacitate its munitions capability.8 The technique
takes its name from the Ancient Greek oracle at Delphi,
which was believed to forecast future events. The main
steps in the Delphi process are summarised in Table 1.Table 2 Agreed research priorities
Disease area(s) What is the research question that needs
Paediatric lung
health/asthma
 Is there a causal relationship betwee
the mechanism through which this re
 Can an intervention to improve cardi
asthma result in improvements in lun
Paediatric
lung health
 Which predisposing genetic loci for se
using a genome-wide association stud
 Can these genetic factors be correlat
collected from infants with mild and
Paediatric lung
health/COPD
 Is there a link between early life lung
 What factors in childhood are import
Asthma/COPD  What is the optimal health service co
Asthma  What is the optimal treatment strate
controlled despite treatment with inh
 Specifically, which of the recommend
(ii) addition of leukotriene receptor a
likely to be beneficial?
 What role do factors such as adheren
factors such as rhinitis have?
 Are there particular asthma genotype
response to one or more of these tre
Lung fibrosis  Can pharmacological therapy with N-
disease progression in patients with iWe used the Delphi approach to undertake our prioriti-
sation, but this was, based on our experiences of un-
dertaking similar prioritisation work in other settings,
adapted in a few key respects to ensure that this exercise
met the needs of the UKRRC, whilst also minimising
inconvenience for the Delphi panel.9,10
UKRRC e-Delphi exercise
This involved all 22 members of the UKRRC serving as our
multi-disciplinary expert panel. At an initial face-to-face
meeting of our expert panel, it was agreed that we would,
for the first year, seek to focus on research questions in
relation to asthma, chronic obstructive pulmonary disease
(COPD) and lung fibrosis, with paediatric lung health being
a cross-cutting area (the plan is in future years to focus on
other respiratory disease areas). Panel members were
invited to anonymously identify questions of national
importance within these areas, together with a short
statement explaining the importance of the proposed
work and possible methodological approaches that could
be used to undertake the study. In the case of asthma this
was greatly helped by a list of priorities already drawn up
by Asthma UK, and a list of broader topics identified by the
British Lung Foundation.
This initial long-list of questions was then circulated to
our expert panel by email, with panel members being
invited to score anonymously each of these questions on
a five point Likert scale, ranging from ‘‘unimportant’’ to
‘‘very important’’. Responses were then collated and fed
back to the panel members electronically; panel members
were then invited to re-score the questions in the light of
this feedback. The resulting summary responses from this
second e-Delphi round allowed individual questions to beto be investigated?
n obesity and asthma in children and, if so, what is
lationship is mediated?
ovascular fitness and reduce weight in obese children with
g function and/or asthma control?
vere bronchiolitis can be detected
y?
ed to measure differences in biological samples
infants with severe disease?
function and the risk of cardiovascular disease?
ant in the development of COPD in adults?
nfiguration for patients with: (i) asthma; and (ii) COPD?
gy for managing patients with asthma who remain poorly
aled steroids and long-acting beta-agonists?
ed treatment options: (i) higher dose inhaled corticosteroid;
ntagonists; and (iii) addition of oral theophylline is most
ce with medication and the role of possible aggravating
s or phenotypes that predict a favourable
atments?
acetylcysteine and/or warfarin reduce
diopathic pulmonary fibrosis?
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face-to-face meeting of the expert panel.Key findings and next steps
We had good engagement with the process as reflected by
an initial list of 22 questions being generated and then 73%
and 68% of panel members responding to the second and
third e-Delphi rounds.
More substantially, through this process we were able to
identify key questions on asthma, COPD, lung fibrosis and
paediatric lung health. The questions detailed in Table 2
are those that have emerged through this process with
high level support from all the major respiratory organisa-
tions in the UK; these therefore form a secure basis for
a series of important national multi-centre studies that
aim to improve lung health.
At the second face-to-face meeting, individuals were
invited to join together and work up an outline commis-
sioning brief for each of the questions agreed upon. Several
such groups have now been formed and these briefs will in
due course be presented to relevant funding bodies, many
of whom have already expressed an interest in issuing
calls in these areas. We hope that these calls will be issued
in 2008.
It is important to note that this represents an early first
step in the long road to raise the profile of respiratory
research in the UK. We are simultaneously pursuing several
other strategies, these include increasing research capacity
by having a greater number of fellowships available, seeking
to develop joint training programmes with industrial part-
ners and working with major generic funding bodies to
create the opportunities to commission the work prioritised
by the UKRRC. Clearly it is important that we do not overlook
other important respiratory disease areas and questions and
given the success of this initial approach, we plan to repeat
this prioritisation exercise in 2008 and beyond with a focus
on other respiratory disease areas and then, within the fields
that formed the substrate for the first prioritisation exercise,
to identify further high priority questions.
Overall, we have found the process to be cohesive and it
has fostered a spirit of collaborative thinking across a very
broad range of organisations and this view is echoed by
a recent report in Nature, describing its use in relation to
policy and research priorities for a broad range of non-com-
municable diseases.11 Based on these positive experiences,
we recommend this approach to respiratory colleagues and
organisations in other countries who may similarly feel
a need to identify national research priorities and collabo-
rative working.
Conflict of interest statement
None of the authors have any conflict of interest in relation
to this work.
Acknowledgements
We would like to express our thanks to UKRRC panel
members and their respective parent organisations fortheir time, enthusiasm and support in contributing to this
process, namely: Professor Stephen Holgate (Chair), Pro-
fessor Jon Ayres (Group of Occupational Respiratory Dis-
ease Specialists), Professor Peter Barnes, Professor Andy
Bush, Professor Peter Calverley, Debbie Campbell (ARNS),
Professor Chris Corrigan (British Society of Allergy &
Clinical Immunology), Dr. Noemi Eiser (British Lung Foun-
dation), Professor Stuart Elborn (Cystic Fibrosis Trust), Dr.
Rachel Garrod (Association of Chartered Physiotherapists in
Respiratory Care), Dr. Meliisa Hack (British Sleep Society),
Dr. Kim Harrison (British Association for Lung Research),
Professor Chris Haslett, Professor Warren Lenney (British
Paediatric Respiratory Society), Dr. Dave Lynes (Respira-
tory Education UK), Clare Newall (Association for Respira-
tory Technology and Physiology), Professor Martyn
Partridge, Dr. Mick Peake, Professor David Price (General
Practitioners in Airways Group), Professor John Price
(Asthma UK Ltd), Dr. Aoife Regan (National Cancer Re-
search Institute), Professor Aziz Sheikh (British Thoracic
Society) and Dr. Samantha Walker (Education for Health).
Our thanks also to the British Thoracic Society for facili-
tating this work.References
1. UK Respiratory Research Collaborative. Available from: http://
www.brit-thoracic.org.uk/page359.html [accessed 02.12.07].
2. Holgate ST. Priorities for respiratory research in the UK. Thorax
2007;62:5e7.
3. Holgate ST. The future of lung research in the UK. Thorax 2007;
62:1028e32.
4. Jones J, Hunter D. Using the Delphi and nominal group tech-
nique in health services research. In: Pope C, Mays N, editors.
Qualitative health research. London: BMJ Books; 2000.
5. Murray Jr JW, Hammons JO. Delphi: a versatile methodology
for conducting qualitative research. Rev Higher Educ 1995;
18:423e36.
6. De Villiers MR, De Villiers PJT, Kent AP. The Delphi technique in
health science education research. Med Teach 2005;27:
639e43.
7. Williams PL, Webb C. The Delphi technique: a methodological
discussion. J Adv Nurs 1994;19:180e6.
8. Dalkey N, Helmer O. An experimental application of the Delphi
method to the use of experts. California: RAND Corporation;
1963.
9. Avery AJ, Savelyich BSP, Sheikh A, Cantrill J, Morris CJ,
Fernando B, et al. Identifying and establishing consensus on
the most important safety features of GP computer systems:
e-Delphi study. Inform Prim Care 2005;13:3e11.
10. Sheikh A, Frank T, Levy M, Dawson A. Identifying pan-European
management goals for asthma: participatory action research
study. Prim Care Respir J 2001;10:69e70.
11. Darr AS, Singer PA, Persad DL, Pramming SK, Matthews DR,
Beaglehole R, et al. Grand challenges in chronic non-communi-
cable diseases. Nature 2007;450:494e6.
Aziz Sheikh*
on behalf of the UKRRC
Allergy and Respiratory Research Group,
Division of Community Health Sciences: GP Section,
University of Edinburgh,
20 West Richmond Street,
Edinburgh EH8 9DX,
UK
1092 Editorial*Corresponding author. Tel.: þ44 (0) 131 650 8102;
fax: þ44 (0) 131 650 9119.
E-mail address: aziz.sheikh@ed.ac.uk
Philippa Major
on behalf of the UKRRC
UK Respiratory Research Committee,
UKStephen T. Holgate
on behalf of the UKRRC
Division of Infection, Inflammation and Repair,
University of Southampton, UK
18 February 2008
Available online 24 June 2008
